The Administrative Office (AO) of the NYUCI plays a crucial role in providing efficient administrative support to the Center Director, Deputy Director, Associate Directors, Core Directors, Program Leaders, and Center Membership. The overall goal is to facilitate research through strategic planning and evaluation initiatives, administration and oversight of core facilities, development of policies and procedures for prudent financial management and grants administration, communications both within the institution and to outside individuals and organizations, human resource management, meetings and seminars, and space and facilities planning. The office is responsible for all interactions with central university finance, sponsored programs, grants management, IRB, Office of Clinical Trials, Human Resources Office, information technology, general accounting and public relations. The AO provides services beyond the activities related to the CCSG such as fiscal management of clinical activities, yet the core mission of the CCSG defines and dictates the structure and decision making processes within the administrative unit. There are eight major areas of focus for research administration: central CCSG administration, grants management, membership, core facilities, structure for inter and intradisciplinary collaborations, research program support, and financial management of the Cancer Institute. Support is requested for only those activities directly related to the CCSG. Since the last review, the administrative office has increased staffing to 17 individuals. This is due in large part to the opening of the Smilow Research Center (3 additional staff to support research administration), faculty recruitment efforts (1 administrative staff), Fellowship Program (one coordinator) and our focus on billing and financial compliance with clinical trials (one financial analyst). There has been significant progress in streamlining financial operations, budgeting, setting fee schedules, invoicing, coordinating research program meetings and seminars, and customizing IT systems for core facilities and clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016087-33S2
Application #
8744995
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-04-01
Project End
2018-02-28
Budget Start
2013-04-01
Budget End
2014-02-28
Support Year
33
Fiscal Year
2013
Total Cost
$31,251
Indirect Cost
$12,814
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Chen, Danqi; Fang, Lei; Mei, Shenglin et al. (2018) Erratum: ""Regulation of Chromatin Assembly and Cell Transformation by Formaldehyde Exposure in Human Cells"". Environ Health Perspect 126:019001
Fan, Xiaozhou; Peters, Brandilyn A; Jacobs, Eric J et al. (2018) Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome 6:59
Wadghiri, Youssef Z; Hoang, Dung Minh; Leporati, Anita et al. (2018) High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease. Sci Rep 8:7687
Khodadadi-Jamayran, Alireza; Akgol-Oksuz, Betul; Afanasyeva, Yelena et al. (2018) Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget 9:12868-12878
Nancy, Patrice; Siewiera, Johan; Rizzuto, Gabrielle et al. (2018) H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest 128:233-247
Wang, Shiyang; Liechty, Benjamin; Patel, Seema et al. (2018) Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neurooncol 138:183-190
Ge, Wenzhen; Clendenen, Tess V; Afanasyeva, Yelena et al. (2018) Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer 142:2215-2226
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Ruggles, Kelly V; Wang, Jincheng; Volkova, Angelina et al. (2018) Changes in the Gut Microbiota of Urban Subjects during an Immersion in the Traditional Diet and Lifestyle of a Rainforest Village. mSphere 3:

Showing the most recent 10 out of 1170 publications